Linkage disequilibrium (LD) analysis of schizophrenia (SC) and schizoaffective disorder (SA) in the Costa Rican Population

Preliminary findings on chromosome 13

M. A. Escamilla, H. Raventos, L. Almasy, P. Montera, T. Balderas, S. Rodriguez, D. Levinson

    Research output: Contribution to journalArticle

    3 Citations (Scopus)

    Abstract

    As the first step in a genome-wide LD screen for SC genes in the Costa Rican population, we report here a preliminary analysis of chromosome 13. Subjects were drawn from the Central Valley of Costa Rica (CVCR), an ideal population for LD mapping of psychiatric disorders (Escamilla et al. 1996). Best estimate consensus diagnoses were made using information from DIGS, FIGS and medical records. ABI LMSV2 markers were used to genotype 102 persons with DSMIV diagnosis of SC or SA, and 189 control chromosomes. Two statistical tests appropriate for model-free LD mapping were used: the CLUMP test of Sham and Curtis and the likelihood association test of Terwilliger. Evidence of LD was found at two contiguous markers in the 13q region (P = .06 at D13S1263 and P = .01 at D13S173). We next genotyped three additional markers near D13S263 and D13S173. One of these (D13S286) showed additional evidence of LD (P = .03). The markers which showed possible LD span a 5.8 cM region which lies within the larger region previously reported to be linked to a gene for SC/S A disorder in a North American population (Blouin et al. 1998). Although results of this magnitude must be interpreted with caution, these preliminary results support the possibility of a SC/SA gene being in the 13q region. Future analyses (including haplotype analyses) with a larger sample from the CRCV should prove useful in proving whether SC/SA predisposition genes are indeed present in this population as well as in providing finer localization of the putative 13q SC/SA gene.

    Original languageEnglish (US)
    Pages (from-to)599
    Number of pages1
    JournalAmerican Journal of Medical Genetics - Neuropsychiatric Genetics
    Volume105
    Issue number7
    StatePublished - Oct 8 2001

    Fingerprint

    Chromosomes, Human, Pair 13
    Linkage Disequilibrium
    Psychotic Disorders
    Schizophrenia
    Population
    Genes
    Chromosome Mapping
    Costa Rica
    Haplotypes
    Medical Records
    Psychiatry
    Consensus
    Chromosomes
    Genotype
    Genome

    ASJC Scopus subject areas

    • Genetics(clinical)
    • Neuropsychology and Physiological Psychology
    • Neuroscience(all)

    Cite this

    Linkage disequilibrium (LD) analysis of schizophrenia (SC) and schizoaffective disorder (SA) in the Costa Rican Population : Preliminary findings on chromosome 13. / Escamilla, M. A.; Raventos, H.; Almasy, L.; Montera, P.; Balderas, T.; Rodriguez, S.; Levinson, D.

    In: American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 105, No. 7, 08.10.2001, p. 599.

    Research output: Contribution to journalArticle

    @article{4abf18846e10493d8f9156da26de3176,
    title = "Linkage disequilibrium (LD) analysis of schizophrenia (SC) and schizoaffective disorder (SA) in the Costa Rican Population: Preliminary findings on chromosome 13",
    abstract = "As the first step in a genome-wide LD screen for SC genes in the Costa Rican population, we report here a preliminary analysis of chromosome 13. Subjects were drawn from the Central Valley of Costa Rica (CVCR), an ideal population for LD mapping of psychiatric disorders (Escamilla et al. 1996). Best estimate consensus diagnoses were made using information from DIGS, FIGS and medical records. ABI LMSV2 markers were used to genotype 102 persons with DSMIV diagnosis of SC or SA, and 189 control chromosomes. Two statistical tests appropriate for model-free LD mapping were used: the CLUMP test of Sham and Curtis and the likelihood association test of Terwilliger. Evidence of LD was found at two contiguous markers in the 13q region (P = .06 at D13S1263 and P = .01 at D13S173). We next genotyped three additional markers near D13S263 and D13S173. One of these (D13S286) showed additional evidence of LD (P = .03). The markers which showed possible LD span a 5.8 cM region which lies within the larger region previously reported to be linked to a gene for SC/S A disorder in a North American population (Blouin et al. 1998). Although results of this magnitude must be interpreted with caution, these preliminary results support the possibility of a SC/SA gene being in the 13q region. Future analyses (including haplotype analyses) with a larger sample from the CRCV should prove useful in proving whether SC/SA predisposition genes are indeed present in this population as well as in providing finer localization of the putative 13q SC/SA gene.",
    author = "Escamilla, {M. A.} and H. Raventos and L. Almasy and P. Montera and T. Balderas and S. Rodriguez and D. Levinson",
    year = "2001",
    month = "10",
    day = "8",
    language = "English (US)",
    volume = "105",
    pages = "599",
    journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
    issn = "1552-4841",
    publisher = "Wiley-Liss Inc.",
    number = "7",

    }

    TY - JOUR

    T1 - Linkage disequilibrium (LD) analysis of schizophrenia (SC) and schizoaffective disorder (SA) in the Costa Rican Population

    T2 - Preliminary findings on chromosome 13

    AU - Escamilla, M. A.

    AU - Raventos, H.

    AU - Almasy, L.

    AU - Montera, P.

    AU - Balderas, T.

    AU - Rodriguez, S.

    AU - Levinson, D.

    PY - 2001/10/8

    Y1 - 2001/10/8

    N2 - As the first step in a genome-wide LD screen for SC genes in the Costa Rican population, we report here a preliminary analysis of chromosome 13. Subjects were drawn from the Central Valley of Costa Rica (CVCR), an ideal population for LD mapping of psychiatric disorders (Escamilla et al. 1996). Best estimate consensus diagnoses were made using information from DIGS, FIGS and medical records. ABI LMSV2 markers were used to genotype 102 persons with DSMIV diagnosis of SC or SA, and 189 control chromosomes. Two statistical tests appropriate for model-free LD mapping were used: the CLUMP test of Sham and Curtis and the likelihood association test of Terwilliger. Evidence of LD was found at two contiguous markers in the 13q region (P = .06 at D13S1263 and P = .01 at D13S173). We next genotyped three additional markers near D13S263 and D13S173. One of these (D13S286) showed additional evidence of LD (P = .03). The markers which showed possible LD span a 5.8 cM region which lies within the larger region previously reported to be linked to a gene for SC/S A disorder in a North American population (Blouin et al. 1998). Although results of this magnitude must be interpreted with caution, these preliminary results support the possibility of a SC/SA gene being in the 13q region. Future analyses (including haplotype analyses) with a larger sample from the CRCV should prove useful in proving whether SC/SA predisposition genes are indeed present in this population as well as in providing finer localization of the putative 13q SC/SA gene.

    AB - As the first step in a genome-wide LD screen for SC genes in the Costa Rican population, we report here a preliminary analysis of chromosome 13. Subjects were drawn from the Central Valley of Costa Rica (CVCR), an ideal population for LD mapping of psychiatric disorders (Escamilla et al. 1996). Best estimate consensus diagnoses were made using information from DIGS, FIGS and medical records. ABI LMSV2 markers were used to genotype 102 persons with DSMIV diagnosis of SC or SA, and 189 control chromosomes. Two statistical tests appropriate for model-free LD mapping were used: the CLUMP test of Sham and Curtis and the likelihood association test of Terwilliger. Evidence of LD was found at two contiguous markers in the 13q region (P = .06 at D13S1263 and P = .01 at D13S173). We next genotyped three additional markers near D13S263 and D13S173. One of these (D13S286) showed additional evidence of LD (P = .03). The markers which showed possible LD span a 5.8 cM region which lies within the larger region previously reported to be linked to a gene for SC/S A disorder in a North American population (Blouin et al. 1998). Although results of this magnitude must be interpreted with caution, these preliminary results support the possibility of a SC/SA gene being in the 13q region. Future analyses (including haplotype analyses) with a larger sample from the CRCV should prove useful in proving whether SC/SA predisposition genes are indeed present in this population as well as in providing finer localization of the putative 13q SC/SA gene.

    UR - http://www.scopus.com/inward/record.url?scp=33749092947&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33749092947&partnerID=8YFLogxK

    M3 - Article

    VL - 105

    SP - 599

    JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

    JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

    SN - 1552-4841

    IS - 7

    ER -